0001209191-18-045024.txt : 20180802 0001209191-18-045024.hdr.sgml : 20180802 20180802171417 ACCESSION NUMBER: 0001209191-18-045024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180801 FILED AS OF DATE: 20180802 DATE AS OF CHANGE: 20180802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mancilla Bethany CENTRAL INDEX KEY: 0001748840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 18989468 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 W. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 675 W. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-01 0 0001645460 Cue Biopharma, Inc. CUE 0001748840 Mancilla Bethany 21 ERIE STREET CAMBRIDGE MA 02139 0 1 0 0 SVP and Chief Business Officer Stock Option (right to buy) 9.54 2018-08-01 4 A 0 250000 0.00 A 2025-08-01 Common Stock 250000 250000 D This stock option grant becomes exercisable in eight equal semi-annual installments beginning February 1, 2019. /s/ Bethany Mancilla by Mark Busch, as attorney-in-fact 2018-08-02